explore -WSS

explore

author：Wikipedia 2025-10-02 22:41:37 - browse：9

accountable care organizations cost saving — Adobe

WASHINGTON — A key Obama-era initiative was supposed to save Medicare money by testing new policies for cutting health care costs. It has so far failed to do so, according to nonpartisan congressional budget experts, and it’s not expected to save money anytime soon.

The 2010 Affordable Care Act created a government center, named the Center for Medicare and Medicaid Innovation, that was given $10 billion over a decade to test new Medicare and Medicaid pay policies. It has since been funded at the same level for another 10 years.

Republicans have attacked the center over the years. Although most of its pilot programs involve lowering hospital spending, some of the center’s initiatives aiming to lower spending on drugs have often provoked GOP ire. Most recently, they attacked the center’s proposal to cut Medicare pay for drugs that receive accelerated approvals. The Trump administration also used pilot programs to cut drug spending, including its failed attempt to tie Medicare drug payments to prices abroad.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： With competition flaring, obesity drug hits goal in liver disease study

hotspot

WSS

PhRMA lawsuit over Medicare drug price negotiation tossed

NIH study of ME/CFS points to clear biological hallmarks

Key House Republican on health care plans exit from Congress

Private equity deals in Medicare Advantage declines

A new nitrogen execution bill also undermines medical licensing

Medicare inequities exacerbate Puerto Rico’s health disparities

leisure time

explore

hotspot

Continuity nursing helped my family in our darkest PICU moments

STAT readers on older presidents, polypills, Medicare, and more

Wildfire smoke exposes gaps in outdoor worker protections

Biden report: The neurospychology of memory and aging

What does generative AI mean for health care? We asked experts

Why did Pfizer dish out millions for a Super Bowl ad?

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

With competition flaring, obesity drug hits goal in liver disease study

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Ed Silverman on new gene therapies, biosimilars, coffee, and more

focus

Alabama hospital puts IVF treatments on hold

Alabama IVF ruling threatens families facing fatal genetic disease

Gilead acquiring CymaBay and its liver disease drug for $4.3 billion

Why palliative psychiatry is worth discussing

Medicare threatens to cut off funding for HCA's Mission hospital

Annovis Bio delivers candor, but not confidence, on Parkinson’s study

focus

focus

hotspot

entertainment